Advanced Search
Contact | Corporate | Help

Daily news email for January 26, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

 b3c newswire
AMSilk to Be Featured on 21st Century Business Television on CNBC and Fox Business Network

Rentschler Manufacturing Facility Wins 2012 Facility of the Year Award in Equipment Innovation

Encap Drug Delivery Adds New Commercial Product to Portfolio

Affectis Granted Patent for AFC-5128, other P2X7 Antagonists

Boehringer Ingelheim Prolongates Drug Discovery Collaboration with Priaxon

 BioSpace
Longer Bones Give Sprinters Speed, Pennsylvania State University Study

ChemoCentryx, Inc. Sets $14-$16 Range for IPO

Kansas Bioscience Authority Audit Slams Former CEO

Illumina, Inc. Plans Poison Pill to Thwart Roche Bid

Ranbaxy Laboratories May Face Permanent Injunction in U.S

BioSpace - Breaking News
IntelliCell BioSciences Filed Patent Application for its Proprietary Method of Manufacturing Stromal Vascular Fraction Cells

Celator Pharmaceuticals, Inc. Receives EMA Orphan Drug Status for CPX-351 in Acute Myeloid Leukemia

Mayo Clinic Release: Combo Treatment Helps Heal Overused, Aching Joints

Advaxis, Inc. Reports Preliminary Safety and Survival Data from a Phase 2 Trial in Recurrent/Refractory Cervical Cancer

REPEAT/Advaxis, Inc. Reports Preliminary Safety and Survival Data from a Phase 2 Trial in Recurrent/Refractory Cervical Cancer

Biotech News - Business Wire
Massachusetts Life Sciences Center Awards $5 Million Grant to Museum of Science for Construction of Hall of Human Life

BIO Congratulates ZeaChem, Applauds USDA Loan Guarantee Announcement

Research and Markets: Medical Nanotechnology Market Guide 2012

BioReference to Launch Groundbreaking Solid Tumor Genotyping Test through its GenPath Oncology Laboratory

US Diagnostic Electrocardiography Device Market to Grow at a Slow Rate of 1.5 Percent Through 2016

 Biotech News - PR Newswire
Lend Lease Announces the Appointment of Tom Chapman as Director Operations for the Life Sciences Group in the Atlantic Region

Aria Announces Publication of Independent Study in the American Journal of Obstetrics & Gynecology Using Aria's Technology

ZyGEM to Provide its Unique DNA and RNA Extraction Technology to Middle East Biomedical Innovator Saudi Diagnostics Ltd.

PDI to Present at the UBS 22nd Annual Global Healthcare Services Conference

Amgen to Acquire Micromet
Biotechnology - Moreover
Celgene reports Q4 adjusted EPS $1.05 vs. consensus $1.06

Celgene affirms FY12 outlook

Celgene sees FY12 EPS $4.70-$4.80 vs. consensus $4.70

Best Relative Performance in the Biotechnology Industry Detected in Shares of Human Genome Sciences (HGSI, ALKS, ITMN, DNDN, CPHD)

Soligenix Receives $574,000 in Non-Dilutive Financing

 Burrill Report
US Obesity Rates Hold Steady

Sanofi Scientist Pleads Guilty to Thefts

Pfizer, Medivation End Development of Alzheimer's Drug

Proteus Debuts Smart Pill in the United Kingdom

Mobile Health App Revenue Perks Up

 CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
Clinical Trials - Business Wire
Research and Markets: Stomatitis (Sore Mouth) Global Clinical Trials Review, H2, 2011

Research and Markets: Dermatitis Global Clinical Trials Review, H2, 2011

BioClinica, Inc. to Present at the UBS 22nd Annual Global Healthcare Services Conference on February 7, 2012 in New York

Research and Markets: Endpoints - Clinical Trials in Cardiovascular Disorders - Optimal Use of Surrogate Endpoints and Clinical Biomarkers are Key Determinants of Success

Research and Markets: Middle East and Africa In Vitro Diagnostics Market Outlook to 2017

 Clinical Trials - PR Newswire
Ortho Caps Files Opposition to Align Technology Patent

Boston IVF Pioneers World's First Needle-Free Saliva Test Used in Infertility Treatment; Patient Friendly Monitoring Replaces Daily Blood Tests

NFID to Host 15th Annual Conference on Vaccine Research

Pycnogenol® (French Maritime Pine Bark Extract) Shown to Improve Visible Signs of Aging in New Clinical Trial

UH Case Medical Center the First in Region to Enroll Patients in Worldwide Study

 CNN Top Stories
Gates donates $750 million to fight diseases

Rescued aid workers arrive at U.S. base

N. Florida voters: Romney's too rich

Aid group: Libya detainees tortured

Last debate before Florida primary
Contract Pharma
Catalent Expands Capabilities at Schorndorf Facility

Patheon Appoints Global Ops President

Financial Report: Bristol-Myers Squibb

Amgen Acquires Micromet

Argenta Appoints BD Leader

 FDA Drugs- What's New
FDA Drug Safety Communication: New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)

Medication Guides

FDA Drug Safety Communication: New Boxed Warning and Contraindication for Adcetris (brentuximab vedotin)

FDA Drug Safety Communication: Update: Preliminary findings from ongoing investigations of CardioGen-82

FDA Statement on recently terminated clinical trial with Doribax (doripenem)

 FDA News - Business Wire
Former FDA Senior Official Michael Chappell Joins Greenleaf Health LLC

Celator® Pharmaceuticals Receives EMA Orphan Drug Status for CPX-351 in Acute Myeloid Leukemia

ASCEND Study to Evaluate the Effectiveness of TYSABRI® (natalizumab) as a Treatment for Secondary-Progressive Multiple Sclerosis

Étude ASCEND pour évaluer l'efficacité de TYSABRI® (natalizumab) en tant que traitement pour la sclérose en plaques progressive secondaire

Lo studio ASCEND valuterà l'efficacia di TYSABRI® (natalizumab) quale trattamento per la sclerosi multipla secondariamente progressiva
FDA Press Releases
Maine company holds cold smoked salmon product after FDA order

FDA permits marketing of first test for risk of rare brain infection in some people treated with Tysabri

FDA approves Voraxaze to treat patients with toxic methotrexate levels

FDA to protect important class of antimicrobial drugs for treating human illness

FDA: Chicago-area sandwich manufacturer agrees to stop production

 FDA Vaccines, Blood and Biologics - What's New
Cord Blood Banking Information for Consumers

Cord Blood Banking – Information for Consumers

Cord Blood Banking ââ¬â Information for Consumers

Influenza Virus Vaccine for the 2011 - 2012 Season

Fluzone, Fluzone High-Dose and Fluzone Intradermal

 FierceBiotech
UPDATED: Amgen scoops up Micromet tumor-fighting pipeline for $1.2B

Amgen scoops up Micromet cancer dug pipeline for $1.2B

UPDATED: Celgene snaps up Avila Therapeutics in $925M buyout

Celgene snaps up Avila Therapeutics in $925M buyout

Increased U.S. aid, rare disease focus drives surge in drug approvals
FierceBiotech IT
Gamers tackle enzyme makeover, beat scientists' efforts

Emerging player in DNA analysis joins forces with U. of Missouri

Oracle, Parexel among leaders in CTMS market poised to hit $1.3B

Oracle injects genomics capability into analytics platform

Consumers to pharma: Let's be Facebook friends (or not)

 FierceBiotech Research
Fight colon cancer with veggies, plus 2 other discoveries

Colorado researchers remove leukemia's shield, making it easier to kill

Targeting NKp46 boosts immune response, Innate Pharma believes

U.K. team finds gene link for esophageal cancer

Genetic analysis yields hypertension clue

 FiercePharma
Bristol-Myers' Q4 shows growth in newer products

Ranbaxy faces 'groundbreaking' oversight with DoJ settlement

Can Roche make $5.7B Illumina bid pay off

Abbott results don't augur well for pharma spinoff

Docs don't heed safety warning on BMS steroid
FiercePharma Manufacturing
Lonza board boots CEO Borgas

Ranbaxy, FDA enter consent decree over GMP, data breaches

Warnings analysis spotlights analytics weakness

Merck 'program of projects' earns facility award

Owner arrested in Pakistani drug deaths cites Big Pharma conspiracy

 FierceVaccines
Hep A vax study underscores need for long-term campaigns

Gen X largely shrugged off call for H1N1 shots

Late-stage Galena vax offers hope for breast cancer patients

Nanoparticles hijack immune response

Researchers target multiple tumors in new cancer vaccine study

Health News - BizJournals.com
Tom Brady connects with organ donor matchup site

HealthGrades: Denver, Colorado Springs among top 50 U.S. metros for hospital care

Judge approves substitute for adult day health care services

Hill-Rom's 1Q sales improve, but profit dips

Clinical depression linked to long work hours
Health News - CNBC
Trius shares fall on SEC investigation

Ahead of the Bell: WellPoint downgraded

Amgen to buy Micromet for $1.16 billion

Bristol-Myers reports rise in 4th-quarter profit

Illumina adopts takeover defense to ward off Roche

 Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

 Inside Industry - Gen
Amgen Ponies Up $1.16B to Buy Micromet for Its mAb Technology

Illumina Institutes Poison Pill to Ward off Roche's $5.7B Purchase Proposal

NIH Wont Survive FY 2013 Without Budget Reduction, GEN Poll Predicts

FDA Clears Leo's Picato Gel for 23 Day Treatment of Actinic Keratosis

President Obama Restates Case for Basic Research in State of the Union Address
Marketwire - Pharma and Biotech
Ora Executives to Present at Allergy Drug Discovery & Development Conference in San Diego

La prueba del PSA abre la puerta a la cura del cer de prta

ProMetic obtient une commande de 2,5 millions $ d'Octapharma

ProMetic Receives $2.5 Million Purchase Order From Octapharma

Theratechnologies to Announce Results for Its 2011 Fiscal Year

 MassBio News
MassBio Introduces the Leading Edge Award

MassBio Policy Update - SBIR Reauthorization

451 Marketing & Freeman to Create Massachusetts Pavilion at 2012 BIO International Convention

Local students explore Biotech Futures

A Note from the President: Looking Forward to a Busy 2012 at MassBio

 Medical Pharma - PR Newswire
The University of Bridgeport and New York Times-bestselling Author Dr. Peter D'Adamo Announce the New Center for Excellence in Generative Medicine

Roche Enters Strategic Alliance with Technoclone to Expand Reagent Portfolio for Coagulation Diagnostics Line Targeted for US and Canada in 2014

Palomar Medical Technologies to Host Fourth Quarter and Year End 2011 Financial Results Conference Call and Webcast on February 9, 2012 at 11:30 AM Eastern Time

Pertussis Cases on the Rise in 2012; DTaP and Tdap Vaccinations Available Daily at MinuteClinic Medical Clinics Nationwide

Interventional Spine, Inc. meldet FDA-Zulassung seines erweiterbaren Zwischenkörpers Opticage zur Behandlung degenerativer Wirbelsäulenerkrankungen
National Center for Biotechnology Information
GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

SRA News

 Nature Biotechnology
Approval on a knife edge

Bringing business risk into sharp focus

The NIH's role in accelerating translational sciences

Building stem-cell genomics in California and beyond

Foundation Medicine

 New York Times- Biotechnology
Amgen and Watson to Work Together on Generic Drugs

A Genome Deluge

Drew Endy: Better Computing for the Things We Care About Most

DNA Sequencing Caught in Deluge of Data

China’s New Economic Plan Focuses on Raising Standards of Living
New York Times- Pharmaceuticals
Johnson & Johnson Takes $3 Billion Charge for Hip Recall

Dutasteride Is Seen to Curtail Cancer Left in Prostate

When the Drug Maker Pays the Doctor

Hard Truths About Disclosure

Who Else Is Paying Your Doctor

 OnBioVC
SeeChange Health, Inc.: Series B $20M

Intervention Insights, Inc.: Series B $7.2M

nanoMR, Inc.: Series B $13M

Circle Cardiovascular Imaging, Inc.: Series B $3.9M

SARcode, Inc.: Series B $44M

 Outsourcing-Pharma
An experienced CMO is key to successful biologics development says Cobra Biologics

Parexel discusses transdermal drug delivery techs

Sponsors and CROs differ on perception of service quality, says the Avoca Group

Recipharm CEO talks CMO sector recovery and Asian plans

Covance adding mass spec for biosimilars
Pharma News - Business Wire
Orange County Healthcare Mergers and Acquisitions Could Have Negative Impact on Pharma

Acsis, Inc. Appoints Paul Allen to Board of Directors

Rite Aid Readies for Nation's Biggest Football Game with Great Deals on Party Essentials

Research and Markets: Radiopharmaceuticals - 2011 Global Strategic Business Report Featuring 65 Companies Including Many Key and Niche Players

Research and Markets: Antipsychotics Market to 2017 - Expected To Decline Due To Patent Expiries of Major Drugs

 Pharma News - PharmiWeb
Rapid H. pylori detection with PYLORITOP® Ag+

Compliance delivered and quality assured with Radiometer's new AQURE point-of-care management system

Syrris custom reactors built for you

Good Hope Hospital chooses SonoSite's M-Turbo®

CANCER RESEARCH UK LAUNCHES TRIAL OF NEW DRUG TO TREAT ACUTE CHILDHOOD LEUKAEMIA

 Pharma News - PR Newswire
Watson Confirms Court Stays Preliminary Injunction

China Health Resource Signs Two New Agreements for the Sale of Gastrodia Valued at $10 Million USD (Corrected*)

Marken Opens New Corporate Offices

Thomson Reuters Helps Brazil's Institute for Applied Economic Research Identify New Generic Drug Opportunities

Thomson Reuters Ajuda Instituto de Pesquisa Economica Aplicada do Brasil a Identificar Novas Oportunidades de Drogas Genéricas
Pharmaceutical - Moreover
Potential Teva Pharmaceutical (TEVA) Trade Targets 18.26% Return

Santen to introduce nutritional supplement Sante Lutax 20 + DHA

Addtech AB Acquires BioNordika Group

Multan: BZU employee on strike

Aurora Algae hails chief operating officer

 PR Leap - Biotech
Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

AL-TAR Services, Inc. Names Robert Nugent Director of Business Development

Ascent Scientific licenses novel clathrin inhibitors from Freie Universität Berlin, University of Newcastle and Children's Medical Research Institute

 PRWeb - Biotechnology
Conferee Networking Sessions at Pittcon 2012 Include Topics of Current...

Emerson Resources Appoints Industry Veteran as Director of Business...

Wellness Goes Wireless: Johns Hopkins Alumnus Helps Close the Gap On...

SynCardia Selected as a Finalist for the 2012 MEDTEC Europe Innovation...

Pharmaceutical Drug Naming Best Practices for 2012: A Pharmaceutical...
PRWeb - Pharmaceuticals
Radiance Skin Therapy & Laser Center, Now Offering New...

Cough and Cold Medicine Manufacturing OTC in the US Industry Market...

Propecia Sexual Side Effects Website Launched by Hissey Kientz, LLP...

Wireless Analytics, LLC Managing Director Erik Eames Joins Telecom...

Interdisciplinary Management of In-Hospital Hyponatremia, Online...

 Scientific American
Children May Be Exposed to Higher Chemical Concentrations Than Their Mothers

Has Petroleum Production Peaked, Ending the Era of Easy Oil

Tame Theory: Did Bonobos Domesticate Themselves

Why The Supreme Court GPS Decision Won't Stop Warrantless Digital Surveillance

Women Feel Pain More Intensely Than Men Do

 Sports - ESPN Basketball
Moser has 18, UNLV dominates OT over BSU

Kansas St. keeps Texas Tech winless in Big 12

Louisville downs Nova to reach .500 in Big East

Duke rebounds, wins 4th straight over Maryland

Moultrie, Miss. State hold off LSU's late charge
Sports News - ESPN
Sources: Bucs close to hiring Schiano as coach

Maisel: The ties that bind

Regents' immigration policy costs UGa recruit

Auburn to replace poisoned oaks if they die

Paterno funeral procession draws thousands

 Xconomy Life Sciences
New England's Rising Biotech CEOs to Gather at April 4 Xconomy Event

Celgene Buys Avila for $350M, Gaining Promising Covalent Drugs

San Diego Life Sciences Roundup: Illumina, Sequenom, Acutus, & More

Theraclone, VLST Founders Form New Antibody Startup, V-Gene

Biotech Is Raising More Cash, But Dont Be Fooled: Startups are Hurting

 Yahoo Biotech News
Gates defends focus on high-tech agriculture (AP)

Thoroughbred Racehorses Get Speed from Just a Few Ancestors (LiveScience.com)

Small Stem Cell Study Claims Early Success in Treating Eye Disease (HealthDay)

New Genetic Clues to Breast Cancer (HealthDay)

Pot-based prescription drug looks for FDA OK (AP)


SourceSolution © 2008-2012